Recipharm AB acquires Abbott Manufacturing Site in Spain
This move further enhances Recipharm’s capabilities, providing a base in the strategically important Spanish market, whilst bringing new customer relationships into the Recipharm Group. It also reinforces Recipharm’s strategic goal to become one of the world’s leading Contract Development and Manufacturing Organisations (CDMO), offering a ‘one-stop shop’ for the development and manufacturing of both small and large molecule biopharmaceuticals.
Recipharm will continue to produce all Abbott products currently manufactured at the site. Recipharm also intends to retain all existing employees.
Most read news
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.